Selective Serotonin Reuptake Inhibitors: all 1,366 studies that test it
Page 10 of 14. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.
- Predicting Medication Response in Obsessive Compulsive DisorderCompletedNCT01404871Not applicable
- Treatment Strategy for Refractory Schizophrenia: Drug Interaction Between Clozapine and FluvoxamineCompletedNCT01401491Phase 4
- Comparison of the Pharmacokinetics of Three Generic Medications and Their Respective Brand PreparationsStatus unknownNCT01400165Phase 1
- Impact of Citalopharm and Fluvoxamine on Platelet Response to ClopidogrelCompletedNCT01396720Phase 1
- Japanese Phase 1 Multiple Ascending Dose (MAD) StudyCompletedNCT01396252Phase 1
- Bioequivalence Study Comparing Two Formulations of EscitalopramCompletedNCT01395433Phase 1
- Long-Term Extension Study of Lu AA21004 in Participants With Major Depressive DisorderCompletedNCT01395147Phase 3
- A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective DisorderStatus unknownNCT01389908Not applicable
- Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major DepressionCompletedNCT01369095Phase 2
- The Quietude Study: Quetiapine Use for Agitated DepressionTerminatedNCT01363310Phase 3
- Long-term Safety and Tolerability of BMS-820836 in the Treatment of Patients With Treatment Resistant Major DepressionTerminatedNCT01361555Phase 2
- Neurophysiologic Monitoring of Antidepressant TreatmentCompletedNCT01360190Phase 4
- Efficacy and Safety of Flexibly Dosed BMS-820836 in the Treatment of Patients With Treatment Resistant Major DepressionCompletedNCT01309945Phase 2
- The Effect of Problem Solving Therapy and Antidepressant Therapy on Cerebral Perfusion and Brain Derived Neurotropic Factor (BDNF) in Depressed EldersCompletedNCT01305889Not applicable
- Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ DepressionCompletedNCT01303601Phase 4
- Cipralex® for Anxiety Disorders in AdolescentsStatus unknownNCT01293838Phase 1
- Depression Care Management for Depressed Elders in China Primary CareStatus unknownNCT01287494Phase 4
- Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant DepressionCompletedNCT01282632Phase 1/2
- The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke PatientsStatus unknownNCT01278498Phase 4
- Comparing Omeprazole With Fluoxetine for Treatment of Non Erosive Reflux Disease and Its Subgroups: a Double-blind Placebo-controlled Clinical TrialCompletedNCT01269788Phase 2/3
- Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg Under Fasting ConditionsCompletedNCT01267396Phase 1
- Bioequivalence Study of Sertraline Hydrochloride Tablets 100 mg in Fed ConditionsCompletedNCT01267383Phase 1
- Neural, Genetic, and Peripheral Correlates of SSRI Pharmaco-ResponseCompletedNCT01251471Phase 4
- Atypical Antipsychotic Treatment Effect On Brain Function In Schizophrenia Measured By FMRICompletedNCT01234454Not applicable
- An Open-Label Study of the Long-Term Safety of Dapoxetine HCl in the Treatment of Rapid EjaculationCompletedNCT01230762Phase 3
- EScitalopram PIndolol ONset of ActionTerminatedNCT01219686Phase 2/3
- Effects of Intravenous (IV) Citalopram on Emotional Brain Activity in Healthy Young and Elderly AdultsTerminatedNCT01216449Not applicable
- Pharmacokinetic Properties of Sertraline Before and After Gastric Bypass SurgeryCompletedNCT01214382Phase 3
- Pharmacogenomics Studies of AntidepressantsStatus unknownNCT01204086Phase 4
- Phase 2 Trial of PED-1 and PED-2 in Male Patients With Premature EjaculationCompletedNCT01203202Phase 2
- Biomarkers of Antidepressant Treatment in Adolescents With Major Depression (The Adolescents MDD Study)CompletedNCT01185977Phase 4
- Antipsychotics and Gene Expression in Soft TissuesCompletedNCT01185743Phase 4
- Evaluation of the Efficacy and Safety of Olanzapine for Anorexia Nervosa in Children and AdolescentsTerminatedNCT01184443Phase 3
- Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules, 90 mg of Dr. Reddy's Under Fasting ConditionCompletedNCT01166100Phase 1
- Bioequivalence Study of Fluoxetine Hydrochloride Delayed-Release Capsules 90 mg of Dr. Reddy's Under Fed ConditionCompletedNCT01166087Phase 1
- Clinical Effectiveness of Newer Antipsychotics in Comparison With Conventional Antipsychotics in SchizophreniaCompletedNCT01164059Phase 4
- Effect of Atypical Antipsychotic Drugs Olanzapine and Amisulpride on Glucose MetabolismCompletedNCT01160991Not applicable
- Pain Inhibition in Patients With Rheumatoid Arthritis and Central Sensitivity SyndromesStatus unknownNCT01154647Not applicable
- Study of Treatment of Depression in Refractory AsthmaStatus unknownNCT01153165Not applicable
- Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fed ConditionsCompletedNCT01149980Phase 1
- Bioequivalence Study of Citalopram Hydrobromide Tablets 40 mg of Dr.Reddy's Laboratories Limited Under Fasting ConditionsCompletedNCT01149967Phase 1
- Effect of Olanzapine on Sleep Electroencephalogram (EEG) in Schizophrenia PatientsCompletedNCT01149577Phase 4
- Efficacy and Tolerability of Escitalopram and Duloxetine in Outpatients With Major Depressive DisorderCompletedNCT01148472Phase 4
- Developing Adaptive Treatment Strategies for Children and Adolescents With Obsessive-compulsive Disorder.CompletedNCT01148316Not applicable
- Comparison of Olanzapine and Metoclopramide For Treatment Of bReakThrough EmesisTerminatedNCT01148264Phase 2
- Fluoxetine in Multiple System Atrophy PatientsCompletedNCT01146548Phase 2
- Trazodone for Sleep Disorders in Alzheimer's DiseaseCompletedNCT01142258Phase 3
- Clozapine and Olanzapine Treatment of AggressionCompletedNCT01123408Not applicable
- Escitalopram Treatment for BPSD in Alzheimer's Disease in Comparison to RisperidoneCompletedNCT01119638Phase 4
- The Effects of Treatment With Sertraline for Noncardiac Chest PainCompletedNCT01114100Phase 4
- Matching Genotypes and Serotonergic Medications for AlcoholismCompletedNCT01113164Phase 1
- Strategic Use of New Generation Antidepressants for DepressionCompletedNCT01109693Phase 4
- Pioglitazone as an Adjunct for Moderate to Severe Depressive DisorderCompletedNCT01109030Phase 2/3
- Neural Responses and Dysphoria: Modulation by a Pharmacological ProbeCompletedNCT01101685Phase 4
- Antidepressants to Promote Recovery of Cardiac Patients Suffering From DepressionTerminatedNCT01099592Phase 4
- Trazodone for SSRI-sexual DsyfunctionCompletedNCT01097980Not applicable
- TMC435-TiDP16-C112 - Interaction Trial With AntidepressantsCompletedNCT01090700Phase 1
- Biomarkers for Outcomes In Late-life Depression (BOLD)CompletedNCT01082237Phase 4
- Trial for Antidepressant Treatment for Negative Symptom of Schizophrenia With NRG1 Risk GenotypeStatus unknownNCT01078870Phase 4
- Standard Comprehensive Intervention to Treat First-episode SchizophreniaStatus unknownNCT01057849Not applicable
- Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of SchizophreniaCompletedNCT01052389Phase 4
- Amitriptyline and Paroxetine Treatment of Major DepressionCompletedNCT01049347Phase 3
- A Study of the Ability of Functional Magnetic Resonance Imaging (fMRI) to Detect and Characterize the Effects of Two Marketed Centrally Active Drugs, Placebo, and RO4917523 in Healthy VolunteersCompletedNCT01045083Phase 1
- Efficacy Study of Transcranial Direct Current Stimulation to Treat Major Depressive DisorderCompletedNCT01033084Phase 2/3
- An 8-week, Open-label Study to Evaluate the Effect of Sertraline on Polysomnogram in Depressive Patients With InsomniaCompletedNCT01032434Not applicable
- Treatment of Postpartum Depression With Psychotherapy and Add-on SertralineCompletedNCT01028482Not applicable
- Efficacy and Safety of Paroxetine Daily Doses of 15 mg and 20 mg in the Treatment of Premature EjaculationCompletedNCT01024491Phase 3
- Open Trial of Escitalopram Treatment for Male Subjects With Posttraumatic Stress DisorderCompletedNCT01024140Not applicable
- Effect of Curcumin as Nutraceutical in Patients of DepressionCompletedNCT01022632Not applicable
- Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With Posttraumatic Stress DisorderStatus unknownNCT01008098Phase 2
- Cognitive Flexibility in Major Depression in the Course of Pharmacological and Psychotherapeutic TreatmentCompletedNCT00993876Not applicable
- The Effect of Selective Serotonin Reuptake Inhibitor (SSRI) Treatment on Affective Symptoms and Fertility Treatment Outcome in Women Undergoing in Vitro Fertilization (IVF)Status unknownNCT00989053Not applicable
- Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)CompletedNCT00977301Phase 1
- The Early Medication Change (EMC) TrialCompletedNCT00974155Phase 4
- Effects of 3 Months of Selective Serotonin Reuptake Inhibitor (SSRI)-Treatment on Metabolism and Hypothalamic-pituitary-adrenal (HPA)-Axis in Young Men Born With Low Birth WeightCompletedNCT00971815Not applicable
- Pharmacokinetics and Pharmacodynamics of Sertraline After Low Dose AdministrationCompletedNCT00969852Phase 4
- Effects on Clinical and Functional Outcome of Escitalopram in Adult Stroke PatientsStatus unknownNCT00967408Phase 4
- Single Dose Study of BMS-820836CompletedNCT00964912Phase 1
- Light, Ion, and Fluoxetine Efficacy (LIFE) in DepressionCompletedNCT00958204Phase 3
- Bioequivalence Study of Sertraline 100 mg Tablet and ZOLOFT Following a 100 mg Dose in Healthy Subjects Under Fed ConditionsCompletedNCT00946036Phase 1
- Assessment of Pituitary Adenylate Cyclase Activating Polypeptide-Brain Derived Neurotrophic Factor (PACAP-BDNF) Signaling System Involvement in Etiology and Treatment of Major DepressionCompletedNCT00944996Not applicable
- Bioequivalence Study of Sertraline 100 mg Tablet and ZOLOFT Following a 100 mg Dose in Healthy Subjects Under Fasting ConditionsCompletedNCT00944242Phase 1
- Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects Under Fasting ConditionCompletedNCT00940238Phase 1
- Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed ConditionCompletedNCT00939835Phase 1
- Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer TreatmentStatus unknownNCT00935675Phase 3
- Development of Escitalopram Genomic Device by Using Candidate Gene Approach and Genome-Wide ScanningStatus unknownNCT00935246Not applicable
- VX-950-TiDP24-C133 - A Phase I Study Investigating the Interaction Between Telaprevir and EscitalopramCompletedNCT00933894Phase 1
- Tardive Dyskinesia and Cognitive FunctionCompletedNCT00926965Phase 4
- Effect of Antidepressants on the Treatment for Korean Major Depressive Disorder PatientsTerminatedNCT00926835Phase 4
- Polypharmacy in Clozapine-resistant SchizophreniaCompletedNCT00918021Phase 4
- The Outcome of Treatment of Traumatised Refugees With Psychotherapy and/or AntidepressantsCompletedNCT00917397Phase 4
- To Demonstrate the Relative Bioavailability of Geneva and Basel (Anafranil) 25 mg Clomipramine Hydrochloride Capsules Under Fasted ConditionsCompletedNCT00913783Phase 1
- To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fasting ConditionsCompletedNCT00913718Phase 1
- To Demonstrate the Relative Bioavailability of Geneva and Dista (Prozac) 20 mg Fluoxetine Hydrochloride Capsules (Pulvules) In Healthy Adult Males Under Fed and Fasted ConditionsCompletedNCT00913588Phase 1
- Metabolic Effects of Antipsychotic Substitution in ChildrenWithdrawnNCT00910780Phase 2/3
- Efficacy and Safety of Selective Serotonin Reuptake Inhibitor (SSRI) in Overactive Bladder PatientsCompletedNCT00902421Phase 4
- Effect of Add-on Citalopram to Risperidone on Negative Symptoms in SchizophreniaCompletedNCT00893256Phase 4
- Multiple-Ascending Dose StudyCompletedNCT00892840Phase 1
- Comparing the Effects of Sertindole and Olanzapine on Cognition (SEROLA)TerminatedNCT00885690Not applicable
- Interaction Study of Timolol Eye Drops and Paroxetine CapsulesCompletedNCT00879099Phase 1